s6y
Company name or ticker
Search
JONAS JEFFREY M
4
Sage Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
Filed
Tuesday, February 7, 2023
Period
Feb 3, 2023
Accession number
0001562180-23-001083
Documents
PRIMARY DOCUMENT
4
JEFF JONAS 2019 POA
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header